Looking ahead, employers may continue to face the competing pressures of employee demand for GLP-1 drugs and concerns about costs
If your BMI at the start of the therapy is below a certain threshold and you are not experiencing other risks or conditions, it may not be enough on its own to be eligible for the Bridge Program
GLP-1 agonists can reduce thirst signals alongside appetite signals
Who Qualifies For a Wegovy Prescription
Christensen MB, Lund AB, Jrgensen NR, Holst JJ, Vilsbll T, Knop FK (2020) Glucose-dependent insulinotropic polypeptide (GIP) reduces bone resorption in patients with type 2 diabetes
individual results vary based on physiology, lifestyle, diet, activity level, and the specific botanical formula